Master in Global Infectious Disease

Georgetown University, located in Washington, United States, offers a unique blend of academic excellence and social responsibility. You'll find a strong sense of community here, with opportunities to engage in public service and social justice. As an international student, you'll be part of a diverse group of 3431 students from around the world, studying at an institution founded in 1789.

Specifically, Georgetown focuses on fields like international relations, business, and medicine, with 200 programs available. The School of Foreign Service and the McDonough School of Business are two examples of its distinguished schools. You'll have access to programs that cover many subjects, helping you develop a deep understanding of your chosen field.

As a student, you'll be based in the dynamic capital of the United States, with all the benefits that come with it. You'll have access to modern facilities, active student clubs, and a unique campus tradition that sets Georgetown apart. For instance, the university's location provides many opportunities for internships and networking, helping you make the most of your time here. With its rich history and commitment to holistic education, Georgetown provides a unique experience that will help you grow both academically and personally.

The Master in Global Infectious Disease is a 2-year program at Georgetown University that focuses on combating infectious diseases worldwide. This Master's degree teaches students to use tools like therapeutics, computational modeling, and public policy to improve health outcomes.

The curriculum includes subjects like disease surveillance, epidemiology, and global health policy, with hands-on components like research projects and case studies. Students develop skills in data analysis, policy development, and community engagement.

Graduates can work as Infectious Disease Specialists, Global Health Consultants, Epidemiologists, Research Scientists, or Health Policy Advisors, employed by organizations like the CDC, WHO, or pharmaceutical companies developing new treatments for infectious diseases.